These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18524997)

  • 21. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 22. Too many drugs?
    Halberstam MJ
    Forum Med; 1979 Mar; 2(3):170-6 concl. PubMed ID: 10316794
    [No Abstract]   [Full Text] [Related]  

  • 23. Availability of anticancer drugs in the United States, Europe, and Japan from 1960 through 1991.
    Brown JS; Bienz-Tadmor B; Lasagna L
    Clin Pharmacol Ther; 1995 Sep; 58(3):243-56. PubMed ID: 7554697
    [No Abstract]   [Full Text] [Related]  

  • 24. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.
    Gadarla M; Kearns AK; Thompson PD
    Am J Cardiol; 2008 Jun; 101(12):1747-8. PubMed ID: 18549851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global drug discovery: Europe is ahead.
    Light DW
    Health Aff (Millwood); 2009; 28(5):w969-77. PubMed ID: 19706628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JUPITER: wake up and smell the coffee--the absolute and relative merits of statin use.
    Jackson G; Citrome L
    Int J Clin Pract; 2009 Mar; 63(3):347-8. PubMed ID: 19222618
    [No Abstract]   [Full Text] [Related]  

  • 30. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strength of evidence for labeled dosing recommendations in renal impairment.
    Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
    Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Orphan drugs].
    Kolár J; Chalabala M; Srámková H
    Ceska Slov Farm; 2001 Mar; 50(2):59-65. PubMed ID: 11288591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The globalization of Europe. Interview by Nan Stone.
    Dekker W
    Harv Bus Rev; 1989; 67(3):90-5. PubMed ID: 10318236
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory watch : First drug for idiopathic pulmonary fibrosis approved in Japan.
    Nat Rev Drug Discov; 2008 Dec; 7(12):966-7. PubMed ID: 19043442
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: the importance of background cardiovascular mortality.
    Kuhlmann MK; Yoshino M; Levin NW
    Hemodial Int; 2004 Oct; 8(4):394-9. PubMed ID: 19379447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs in Europe.
    De Haen P
    N Y State J Med; 1973 Mar; 73(6):777-80. PubMed ID: 4510962
    [No Abstract]   [Full Text] [Related]  

  • 38. Approved drugs and their problems in patient care: routes of administration and dosing.
    Cook SD
    J Neurol Sci; 2007 Aug; 259(1-2):38-41. PubMed ID: 17362996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New drug developments in the Latin Americas (Argentina, Costa Rica, Mexico and Panama).
    Ban TA; Galvan L; Udabe RU; Vergara L; Zoch C
    Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):33-6. PubMed ID: 17894101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G; Prats S; Bregni C
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.